Violet Therapeutics

Violet Therapeutics is a preclinical-stage company leveraging a first-in-class platform to systematically identify, map, and mine the cellular connectome at scale. Violet’s initial drug discovery programs focus on central nervous system disorders caused by novel targets elucidated through its platform. Violet was co-founded in 2021 by scientists from Mass General Brigham Ventures and Brigham and Women’s Hospital.